Status:
COMPLETED
Topical Agent for Treatment of Red Skin
Lead Sponsor:
Mayo Clinic
Conditions:
Rosacea
Bilaterally Symmetric Red Skin on Cheeks
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face ...
Eligibility Criteria
Inclusion
- Bilaterally symmetric red skin on cheeks Caucasian Age 18-60 years
Exclusion
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00279890
Start Date
July 1 2005
End Date
January 1 2007
Last Update
May 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Scottsdale, Arizona, United States, 55259